RVL Pharmaceuticals plc Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions
RVL Pharmaceuticals plc reported Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions of $4.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-20.
Discontinued › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions · last filed 2023-03-20
- RVL Pharmaceuticals plc unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2022 was $4.00K, a 0.00% change from fiscal 2021.
- RVL Pharmaceuticals plc unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2021 was $4.00K, a 97.66% decline from fiscal 2020.
- RVL Pharmaceuticals plc unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2020 was $171.00K.
- RVL Pharmaceuticals plc unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2018 was $571.00K.
| Period end | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions 12 month |
|---|---|
| 2022-12-31 | $4.00K 10-K · filed 2023-03-20 |
| 2021-12-31 | $4.00K 10-K · filed 2023-03-20 |
| 2020-12-31 | $171.00K 10-K · filed 2022-03-30 |
| 2019-12-31 | $459.00K 8-K · filed 2021-09-08 |
| 2018-12-31 | $571.00K 10-K · filed 2020-03-19 |